SCHEMBL17035014

SCHEMBL17035014

c1ccc(-c2nc3ccccc3c3c2cc(-c2cc(-c4cccnc4)cc(-c4nc(-c5cccc6ccccc56)nc(-c5cccc6ccccc56)n4)c2)c2ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CLK4 Q9HAZ1 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2D6 P10635 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
GLA P06280 1/20 0.38
KMT2A Q03164 1/20 0.38
GBA1 P04062 6/20 0.38
ABCG2 Q9UNQ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035004 0.92 CYP1A2 (0.45) ALDH1A1MAPTCYP11B1CYP1A2CYP3A4
SCHEMBL17035012 0.90 MEN1 (0.39) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL17035017 0.89 CYP1A2 (0.44) ALDH1A1MAPTCYP11B1CYP1A2CYP3A4
SCHEMBL17035015 0.89 MEN1 (0.40) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL17034933 0.89 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EHPGDRAB9A
SCHEMBL19036097 0.88 CYP11B1 (0.48) ALDH1A1MAPTKDM4EHPGDRAB9A
SCHEMBL19036096 0.88 CYP11B1 (0.50) ALDH1A1MAPTKDM4EHPGDRAB9A
SCHEMBL17035023 0.88 CYP11B1 (0.48) ALDH1A1MAPTHPGDCYP11B1CYP1A2
SCHEMBL17034960 0.88 CYP11B1 (0.48) ALDH1A1MAPTHPGDCYP11B1CYP1A2
SCHEMBL17035009 0.88 CYP11B1 (0.48) ALDH1A1MAPTRAB9ACYP11B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALDH1A1 753/4885MAPT 1406/4885KDM4E 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.